Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)

Journal Article · · J. Med. Chem.
; ; ; ; ; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1832555
Journal Information:
J. Med. Chem., Vol. 64, Issue (16)
Country of Publication:
United States
Language:
ENGLISH

References (39)

Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain journal June 2009
Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease journal September 2002
CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease journal October 2012
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls journal May 2002
24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia journal January 2002
Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? journal April 2006
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease journal May 2010
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice journal October 2020
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway journal February 1997
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen journal September 2007
A second class of nuclear receptors for oxysterols: Regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol) journal August 2010
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors journal October 2013
Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease journal October 2013
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease journal January 2016
CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease journal July 2015
Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease journal January 2010
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease journal September 2017
In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds journal October 2019
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice journal May 2019
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development journal October 2018
Therapeutic advances in Dravet syndrome: a targeted literature review journal August 2020
A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies journal August 2021
Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain journal July 2008
Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain journal October 2010
In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine journal August 2012
The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo journal February 2010
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1 journal April 2013
Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1: UNUSUAL FEATURES AND SPECTRAL RESPONSE journal January 2013
Palladium-Catalyzed Cross-Coupling Reactions of DiazineN-Oxides with Aryl Chlorides, Bromides, and Iodides journal November 2006
H295R cells as a model for steroidogenic disruption: A broader perspective using simultaneous chemical analysis of 7 key steroid hormones journal March 2012
Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindanein vitro journal January 2006
Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1 journal April 2008
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
MOLREP an Automated Program for Molecular Replacement journal December 1997
The CCP4 suite programs for protein crystallography journal September 1994
REFMAC 5 for the refinement of macromolecular crystal structures journal March 2011
Features and development of Coot journal March 2010
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions journal January 1995

Similar Records

Related Subjects